FDA REQUIRES TESTOSTERONE LABELING TO WARN ABOUT INCREASED CARDIOVASCULAR RISK
March 3, 2015 - FDA issued an update to its 2014 Drug Safety Communication, requiring all manufacturers of testosterone products to revise their labels with warnings "about a possible increased risk of heart attacks and strokes..." The updated Safety Communication [...]